Exact Imaging scores Chinese investment

Canadian microultrasound technology developer Exact Imaging has received a $3 million Canadian ($2.3 million U.S.) investment from BioSciKin of China.

The capital infusion from BioSciKin is part of Exact Imaging's $20.7 million ($15.7 million U.S.) fundraising initiative to commercialize its ExactVu technology for prostate cancer imaging.

Exact Imaging expects the investment to close in the fourth quarter, pending the completion of due diligence.

Page 1 of 512
Next Page